Two big AI exits to watch
Markets are bracing for major AI IPOs this year — two 'massive' listings are being tracked by investors as 2026 exit catalysts reported. At the same time, AI health spinout Waiv closed a $33M round after spinning out of Owkin, signaling real demand for AI-enabled precision medicine startups reported.
The two companies named explicitly are OpenAI [and Anthropic] 247wallst.com, with coverage placing OpenAI as a potential $1 trillion valuation candidate and Anthropic in the roughly $350B–$400B range. 247wallst.com OpenAI’s timeline has public-facing signals that push a listing out of 2026, with CFO Sarah Friar [cited as suggesting 2027 as a likely window] interactivebrokers.com and sell-side models forecasting an IPO that could raise tens of billions — the scale that underpins the $1T valuation talk. alpha-sense.com Anthropic has taken concrete IPO-prep steps, including early legal and advisory hires reported in press coverage — the company [was reported to have engaged Wilson Sonsini] invezz.com — while trade reports highlight Anthropic’s enterprise/safety positioning and multi‑billion revenue targets cited in some analyses. daily-ai.info Waiv — the diagnostics outfit spun out from Owkin’s clinical AI unit — plans to commercialize AI-driven digital histopathology products such as RlapsRisk BC already described as used in clinical settings, per trade coverage. hlth.com The new company’s backers include OTB Ventures and Alpha Intelligence Capital, with Serena Data Ventures, Karista and SistaFund named as participants in the investment round. precisionmedicineonline.com
